Melitracen
![Skeletal formula of melitracen](/Images/godic/202501/26/Melitracen-structure1021.png")
![Ball-and-stick model of the melitracen molecule](/Images/godic/202501/26/Melitracen-3D-balls1021.png")
Melitracen (Adaptol, Dixeran, Melixeran, Thymeol, Trausabun) is a tricyclic antidepressant (TCA) marketed in Europe and Japan by Lundbeck and Takeda, respectively, for the treatment of depression and anxiety. In addition to single drug preparations, it is also available as Deanxit, a combination product containing both melitracen and flupentixol.